Drugs of Abuse Testing Assays
6-Acetylmorphine
AB-PINACA
- ARK AB-PINACA Assay
- Immunalysis Synthetic Cannabinoids-3 HEIA
Amphetamines
- Immunalysis Amphetamines HEIA
Barbiturates
- Immunalysis Barbiturates HEIA
Benzodiazepines
Benzoylecgonine (Cocaine Metab.)
- Immunalysis Benzoylecgonine HEIA
Buprenorphine
Cannabinoids
- Immunalysis Cannabinoids HEIA
Carisoprodol
- Immunalysis Carisoprodol HEIA
EDDP
- ARK EDDP Assay
- Immunalysis EDDP Specific HEIA
Ethylglucuronide (EtG)
Fentanyl
JWH-018
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-1 HEIA
Ketamine
Meperidine
- ARK Meperidine Assay
- Immunalysis Meperidine HEIA
Methamphetamine
- Immunalysis Methamphetamine HEIA
Methylphenidate-Metabolite
Opiates
- Immunalysis Opiates HEIA
Oxycodone
- Immunalysis Oxycodone HEIA
Phencyclidine (PCP)
- Immunalysis Phencyclidine HEIA
Pregabalin
Tapentadol
- Immunalysis Tapentadol HEIA
Tramadol
- ARK Diagnostics Tramadol Assay
- Immunalysis Tramadol HEIA
UR-144 / XLR-11
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-2 HEIA
Zolpidem
- Immunalysis Zolpidem HEIA
ARK Pregabalin II Assay

The ARK Pregabalin II Assay provides a reliable and fast method for detecting pregabalin in urine. This innovative homogeneous enzyme immunoassay serves as a straightforward alternative to more complex chromatographic methods, making it particularly useful for monitoring potential cases of pregabalin abuse. Its compatibility with major clinical-chemistry systems allows for easy integration into current drug screening processes.
- Rapid and convenient screening method
- Highly specific method for the determination of pregabalin in human urine
- No cross-reactivity with gabapentin at 5,000 µg/mL
- No cross-reactivity with L-amino acids at 200 µg/mL
- Tested endogenous compounds did not show any interference with the assay
- Liquid, ready-to-use reagents, calibrators and controls
- Storage at 2-8°C
- On-board stability for at least 60 days
- Application protocols for all major clinical chemistry analyzers